DE69603314D1 - Verfahren zur Herstellung von Sulfiden - Google Patents

Verfahren zur Herstellung von Sulfiden

Info

Publication number
DE69603314D1
DE69603314D1 DE69603314T DE69603314T DE69603314D1 DE 69603314 D1 DE69603314 D1 DE 69603314D1 DE 69603314 T DE69603314 T DE 69603314T DE 69603314 T DE69603314 T DE 69603314T DE 69603314 D1 DE69603314 D1 DE 69603314D1
Authority
DE
Germany
Prior art keywords
sulfides
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69603314T
Other languages
English (en)
Other versions
DE69603314T2 (de
Inventor
Ryuzou Watanabe
Shinri Tanaka
Katsuji Ota
Michiko Nagato
Tomio Horiuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konica Minolta Inc
Original Assignee
Konica Minolta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11460095A external-priority patent/JP3491211B2/ja
Priority claimed from JP27019995A external-priority patent/JP3744032B2/ja
Application filed by Konica Minolta Inc filed Critical Konica Minolta Inc
Publication of DE69603314D1 publication Critical patent/DE69603314D1/de
Application granted granted Critical
Publication of DE69603314T2 publication Critical patent/DE69603314T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69603314T 1995-05-12 1996-05-09 Verfahren zur Herstellung von Sulfiden Expired - Fee Related DE69603314T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11460095A JP3491211B2 (ja) 1995-05-12 1995-05-12 4−アリールチオ−5−ピラゾロン類の合成方法
JP21743595 1995-08-25
JP27019995A JP3744032B2 (ja) 1995-08-25 1995-10-18 スルフィド類の製造方法

Publications (2)

Publication Number Publication Date
DE69603314D1 true DE69603314D1 (de) 1999-08-26
DE69603314T2 DE69603314T2 (de) 1999-12-16

Family

ID=27312774

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69603314T Expired - Fee Related DE69603314T2 (de) 1995-05-12 1996-05-09 Verfahren zur Herstellung von Sulfiden

Country Status (3)

Country Link
US (1) US5763618A (de)
EP (1) EP0742200B1 (de)
DE (1) DE69603314T2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2857344C (en) 2011-12-21 2019-02-12 Novira Therapeutics, Inc. Hepatitis b antiviral agents
NZ743499A (en) 2012-08-28 2019-09-27 Janssen Sciences Ireland Uc Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
US9828345B2 (en) 2013-02-28 2017-11-28 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
EA027194B1 (ru) 2013-02-28 2017-06-30 Янссен Сайенсиз Айрлэнд Юси Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
US8993771B2 (en) 2013-03-12 2015-03-31 Novira Therapeutics, Inc. Hepatitis B antiviral agents
BR112015025052A2 (pt) 2013-04-03 2021-07-06 Janssen Sciences Ireland Uc derivados de n-fenil-carboxamida e o seu uso como medicamentos para o tratamento da hepatite b
JO3603B1 (ar) 2013-05-17 2020-07-05 Janssen Sciences Ireland Uc مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
TR201807090T4 (tr) 2013-07-25 2018-06-21 Janssen Sciences Ireland Uc Glioksamid sübstitüeli pirrolamid deriveleri ve bunun hepatitin tedavisine yönelik ilaçlar olarak kullanımı.
JP6452119B2 (ja) 2013-10-23 2019-01-16 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー カルボキサミド誘導体およびb型肝炎の処置のための医薬品としてのその使用
US9169212B2 (en) 2014-01-16 2015-10-27 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis B infections
US10392349B2 (en) 2014-01-16 2019-08-27 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis B infections
US9181288B2 (en) 2014-01-16 2015-11-10 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis B infections
WO2015120178A1 (en) 2014-02-05 2015-08-13 Novira Therapeutics, Inc. Combination therapy for treatment of hbv infections
UY35980A (es) 2014-02-06 2015-08-31 Janssen Sciences Ireland Uc Derivados de sulfamoilpirrolamida como inhibidores del hbv y composiciones farmacéuticas que los contienen
US9400280B2 (en) 2014-03-27 2016-07-26 Novira Therapeutics, Inc. Piperidine derivatives and methods of treating hepatitis B infections
CA2980298A1 (en) 2015-03-19 2016-09-22 Novira Therapeutics, Inc. Azocane and azonane derivatives and methods of treating hepatitis b infections
US10875876B2 (en) 2015-07-02 2020-12-29 Janssen Sciences Ireland Uc Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
CN108430971A (zh) 2015-09-29 2018-08-21 诺维拉治疗公司 乙型肝炎抗病毒剂的晶体形式
SG11201808949SA (en) 2016-04-15 2018-11-29 Novira Therapeutics Inc Combinations and methods comprising a capsid assembly inhibitor
CR20200378A (es) 2018-03-14 2021-01-08 Janssen Sciences Ireland Unlimited Co Régimen posológico del modulador del emsalblaje de la cápside
CN113454077A (zh) 2019-02-22 2021-09-28 爱尔兰詹森科学公司 用于治疗hbv感染或hbv诱发的疾病的酰胺衍生物
EP3966205A1 (de) 2019-05-06 2022-03-16 Janssen Sciences Ireland Unlimited Company In der behandlung einer hbv-infektion oder von hbv-induzierten erkrankungen nützliche amidderivate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405969A (en) * 1993-12-10 1995-04-11 Eastman Kodak Company Manufacture of thioether compounds

Also Published As

Publication number Publication date
EP0742200B1 (de) 1999-07-21
DE69603314T2 (de) 1999-12-16
US5763618A (en) 1998-06-09
EP0742200A1 (de) 1996-11-13

Similar Documents

Publication Publication Date Title
DE69704964T2 (de) Verfahren zur Herstellung von Acryloxypropylsilane
DE59600015D1 (de) Verfahren zur Herstellung von Thermoplasten
DE69603314D1 (de) Verfahren zur Herstellung von Sulfiden
DE69520202T2 (de) Verfahren zur Herstellung von Polyphenylensulfid
DE69617601T2 (de) Verfahren zur Herstellung von thermoplastische Elastomerzusammensetzung
DE59600302D1 (de) Verfahren zur Herstellung von Thermoplasten
DE69621491T2 (de) Verfahren zur Herstellung von Epsilon-Caprolactam
DE59600373D1 (de) Verfahren zur Herstellung von Thermoplasten
DE59707913D1 (de) Kontinuierliches Verfahren zur Herstellung von gamma- Aminopropyltrialkoxysilanen
DE69510596T2 (de) Verfahren zur Herstellung von Organooxysilane
DE59600724D1 (de) Verfahren zur Herstellung von Astaxanthin
DE69615660D1 (de) Verfahren zur herstellung von lactamen
DE69611484D1 (de) Verfahren zur Herstellung von Phenol
DE59600080D1 (de) Verfahren zur Herstellung von Thermoplasten
DE69613806D1 (de) Verfahren zur Herstellung von Pigmenten
DE69310232D1 (de) Verfahren zur Herstellung von Organomonochlorsilan
DE59602996D1 (de) Verfahren zur Herstellung von Alkoholaten
DE59302489D1 (de) Verfahren zur Herstellung von Chlor-Fluor-Butenen
DE69611331T2 (de) Verfahren zur Herstellung von S-Phenyl-L-Cystein
DE69702327D1 (de) Verfahren zur Herstellung von Siliziumsulfid
DE69627117T2 (de) Verfahren zur Herstellung von Zellulose
DE69603243D1 (de) Verfahren zur Herstellung von Ethenylamiden
DE69700508T2 (de) Verfahren zur Herstellung von Organodisilanen
DE69609804T2 (de) Verfahren zur Herstellung von Fluorenon
DE69620974D1 (de) Verfahren zur Herstellung von Acetalen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee